Antibody‐drug therapeutic conjugates: Potential of antibody‐siRNAs in cancer therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody‐drug therapeutic conjugates: Potential of antibody‐siRNAs in cancer therapy
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-03-26
DOI
10.1002/jcp.28490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody based EpCAM targeted Therapy of Cancer, Review and update
- (2018) Shirin Eyvazi et al. CURRENT CANCER DRUG TARGETS
- Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates
- (2018) Balázs Bobály et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Market watch: Top drugs and companies by sales in 2017
- (2018) Lisa Urquhart NATURE REVIEWS DRUG DISCOVERY
- Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
- (2018) Marco B. Schaaf et al. Cell Death & Disease
- Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System
- (2018) Ana C.N. Oliveira et al. CURRENT DRUG TARGETS
- Analytical techniques for the characterization of Antibody Drug Conjugates: Challenges and prospects
- (2017) Rabin Neupane et al. EUROPEAN JOURNAL OF MASS SPECTROMETRY
- Identification of a novel single chain fragment variable antibody targeting CD24-expressing cancer cells
- (2017) Shirin Eyvazi et al. IMMUNOLOGY LETTERS
- Prospects of siRNA applications in regenerative medicine
- (2017) Fatemeh Mottaghitalab et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Biodegradable nano-polymers as delivery vehicles for therapeutic small non-coding ribonucleic acids
- (2017) Ahad Mokhtarzadeh et al. JOURNAL OF CONTROLLED RELEASE
- Solid nano-in-nanoparticles for potential delivery of siRNA
- (2017) Orit Amsalem et al. JOURNAL OF CONTROLLED RELEASE
- Targeted cancer therapy through antibody fragments-decorated nanomedicines
- (2017) Abbas Alibakhshi et al. JOURNAL OF CONTROLLED RELEASE
- Theranostics Using Antibodies and Antibody-Related Therapeutics
- (2017) Kirsten L. Moek et al. JOURNAL OF NUCLEAR MEDICINE
- Antibody–Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections
- (2017) Sanjeev Mariathasan et al. TRENDS IN MOLECULAR MEDICINE
- Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies
- (2017) Neda Shajari et al. Current Drug Delivery
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
- (2017) Katyayani Tatiparti et al. Nanomaterials
- Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy
- (2017) Dinesh Kumar Mishra et al. Drug Delivery and Translational Research
- Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers
- (2017) Roghaye Arezumand et al. Frontiers in Immunology
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
- (2017) Michael A. Cannarile et al. Journal for ImmunoTherapy of Cancer
- Delivery strategies and potential targets for siRNA in major cancer types
- (2016) So Jin Lee et al. ADVANCED DRUG DELIVERY REVIEWS
- Co-delivery of drugs and plasmid DNA for cancer therapy
- (2016) Pei Yun Teo et al. ADVANCED DRUG DELIVERY REVIEWS
- Antibody-drug conjugates—an emerging class of cancer treatment
- (2016) Nikolaos Diamantis et al. BRITISH JOURNAL OF CANCER
- Engineering antibody therapeutics
- (2016) Mark L Chiu et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy
- (2016) Bo Xiao et al. Expert Opinion on Drug Delivery
- Chemically Programmed Bispecific Antibodies in Diabody Format
- (2016) Even Walseng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
- (2016) Tsukasa Sugo et al. JOURNAL OF CONTROLLED RELEASE
- Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
- (2016) Laurie H Sehn et al. LANCET ONCOLOGY
- Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy
- (2016) Maria-Elisabeth Goebeler et al. LEUKEMIA & LYMPHOMA
- Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA
- (2016) Jessica L. Cohen et al. MOLECULAR PHARMACEUTICS
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- (2016) Flora Peyvandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Versatile strategy for controlling the specificity and activity of engineered T cells
- (2016) Jennifer S. Y. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- Antibody-drug conjugates as novel anti-cancer chemotherapeutics
- (2015) C. Peters et al. BIOSCIENCE REPORTS
- Antibody-Mediated Delivery of Anti-KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
- (2015) S. Baumer et al. CLINICAL CANCER RESEARCH
- Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules
- (2015) Min Soo Kim et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Multifunctional receptor-targeting antibodies for cancer therapy
- (2015) Yanni Zhu et al. LANCET ONCOLOGY
- Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
- (2015) Marije B Overdijk et al. mAbs
- Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs
- (2015) Christopher R. Behrens et al. MOLECULAR PHARMACEUTICS
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- Advances in Anticancer Immunotoxin Therapy
- (2015) C. Alewine et al. ONCOLOGIST
- Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
- (2015) Masami Suzuki et al. Journal of Toxicologic Pathology
- Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
- (2015) David M. Goldenberg et al. Oncotarget
- siRNA Versus miRNA as Therapeutics for Gene Silencing
- (2015) Jenny K W Lam et al. Molecular Therapy-Nucleic Acids
- Delivery systems for siRNA drug development in cancer therapy
- (2015) Cong-fei Xu et al. Asian Journal of Pharmaceutical Sciences
- Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency
- (2015) Roger R. Beerli et al. PLoS One
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Chemoenzymatic Strategy for the Synthesis of Site-Specifically Labeled Immunoconjugates for Multimodal PET and Optical Imaging
- (2014) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- Transglutaminase-Based Chemo-Enzymatic Conjugation Approach Yields Homogeneous Antibody–Drug Conjugates
- (2014) Patrick Dennler et al. BIOCONJUGATE CHEMISTRY
- Antibody–drug conjugates—A new wave of cancer drugs
- (2014) Hervé Bouchard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies
- (2014) Yan Deng et al. GENE
- Macrophages eliminate circulating tumor cells after monoclonal antibody therapy
- (2014) Nuray Gül et al. JOURNAL OF CLINICAL INVESTIGATION
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
- (2014) Trinna L. Cuellar et al. NUCLEIC ACIDS RESEARCH
- Methods to Make Homogenous Antibody Drug Conjugates
- (2014) Toni Kline et al. PHARMACEUTICAL RESEARCH
- Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
- (2014) Chong Sun et al. TRENDS IN BIOCHEMICAL SCIENCES
- Chemically programmed antibodies
- (2014) Christoph Rader TRENDS IN BIOTECHNOLOGY
- γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay
- (2014) Ursula Jördis Eva Seidel et al. Frontiers in Immunology
- Metabolic Engineering of Monoclonal Antibody Carbohydrates for Antibody–Drug Conjugation
- (2013) Nicole M. Okeley et al. BIOCONJUGATE CHEMISTRY
- Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry
- (2013) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
- (2013) Scott C. Jeffrey et al. BIOCONJUGATE CHEMISTRY
- Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug
- (2013) J. M. Rowe et al. BLOOD
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
- (2013) Pavel Strop et al. CHEMISTRY & BIOLOGY
- Targeting tumors with nanobodies for cancer imaging and therapy
- (2013) Sabrina Oliveira et al. JOURNAL OF CONTROLLED RELEASE
- Site-Specific Antibody–Polymer Conjugates for siRNA Delivery
- (2013) Hua Lu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
- (2013) Michael Ritchie et al. mAbs
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Materials innovation for co-delivery of diverse therapeutic cargos
- (2013) Megan E. Godsey et al. RSC Advances
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- Effective suppression of breast tumor growth by an anti-EGFR/ErbB2 bispecific antibody
- (2012) Shuhui Wang et al. CANCER LETTERS
- Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies
- (2012) K. Tamada et al. CLINICAL CANCER RESEARCH
- Nanotechnology applied to overcome tumor drug resistance
- (2012) Zibin Gao et al. JOURNAL OF CONTROLLED RELEASE
- Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
- (2012) M. J. W. D. Vosjan et al. MOLECULAR CANCER THERAPEUTICS
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR
- (2012) S. A. Kazane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies
- (2012) Britta Schneider et al. Molecular Therapy-Nucleic Acids
- Humanized Lewis-Y Specific Antibody Based Delivery ofSTAT3siRNA
- (2011) Yuelong Ma et al. ACS Chemical Biology
- Antibody Conjugate Therapeutics: Challenges and Potential
- (2011) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
- (2011) Rob C. Roovers et al. INTERNATIONAL JOURNAL OF CANCER
- Stimulated T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
- (2011) A.-H. Capietto et al. JOURNAL OF IMMUNOLOGY
- Advances in the assessment and control of the effector functions of therapeutic antibodies
- (2011) Xu-Rong Jiang et al. NATURE REVIEWS DRUG DISCOVERY
- Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- (2010) J. R. Junutula et al. CLINICAL CANCER RESEARCH
- Maytansinoid-Antibody Conjugates Induce Mitotic Arrest by Suppressing Microtubule Dynamic Instability
- (2010) E. Oroudjev et al. MOLECULAR CANCER THERAPEUTICS
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
- (2009) Laurent Ducry et al. BIOCONJUGATE CHEMISTRY
- Complement in antibody therapy: friend or foe?
- (2009) M. Introna et al. BLOOD
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- RNAi-based therapeutics-current status, challenges and prospects
- (2009) Katrin Tiemann et al. EMBO Molecular Medicine
- siRNA Conjugate Delivery Systems
- (2008) Ji Hoon Jeong et al. BIOCONJUGATE CHEMISTRY
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now